10-Q Filing

REGENXBIO INC. CIK: 1590877 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-037775`
Period End Date	20200630
Filing Date	20200806
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	rgnx-10q_20200630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 79 Income Statement 72 Cash Flow Statement 63 Stockholders Equity 30

Balance Sheet 79 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$55.14M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$69.51M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$94.22M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$226.70M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$174.96M	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$38.15M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$42.88M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$9.75M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$6.47M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.27M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.29M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.20M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	36.99M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.29M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$345.03M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	36.99M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$329.08M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$103.78M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$70.05M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetNoncurrent`	$3.62M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetNoncurrent`	$4.16M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$28.97M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$32.70M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$10.08M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$8.63M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.05M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.55M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.32M	USD	Point-in-time
Total assets	`Assets`	$497.91M	USD	Point-in-time
Total assets	`Assets`	$449.74M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.41M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.90M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$25.84M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$24.85M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$450.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.42M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.01M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$40.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.68M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.33M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$4.01M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.87M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$7.08M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$582.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.83M	USD	Point-in-time
Total liabilities	`Liabilities`	$47.71M	USD	Point-in-time
Total liabilities	`Liabilities`	$51.88M	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at June 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at June 30, 2020 and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2020 and December 31, 2019; 37,190 and 36,992 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2020 and December 31, 2019; 37,190 and 36,992 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$648.73M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$627.81M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$205.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$750.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-177.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-251.62M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$487.05M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$420.15M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$397.86M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$494.59M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$508.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$450.20M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$497.91M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$449.74M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.88M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$16.57M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$8.77M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$34.21M	USD	2 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$1.96M	USD	2 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$8.09M	USD	2 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$4.68M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$1.93M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$38.11M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$54.69M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$75.15M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$29.48M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$13.40M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$24.96M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$15.55M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$30.39M	USD	2 Qtrs
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$62.00K	USD	2 Qtrs
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$-117.00K	USD	2 Qtrs
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$62.00K	USD	1 Quarter
Other operating expenses (income)	`OtherOperatingIncomeExpenseNet`	$-50.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$44.75M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$113.74M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$81.54M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$58.40M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-36.87M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-41.83M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-79.53M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-72.78M	USD	2 Qtrs
Interest income from licensing	`InterestIncomeFromLicencing`	$762.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$1.85M	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$2.70M	USD	2 Qtrs
Interest income from licensing	`InterestIncomeFromLicencing`	$1.38M	USD	2 Qtrs
Investment income	`InvestmentIncomeNet`	$5.72M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$34.52M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$37.52M	USD	2 Qtrs
Investment income	`InvestmentIncomeNet`	$2.54M	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$7.57M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$5.23M	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$35.29M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$38.89M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-74.30M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-34.26M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-33.88M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.59M	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-199.00K	USD	2 Qtrs
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-500.00K	USD	2 Qtrs
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-129.00K	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-500.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-33.76M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-33.69M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-73.80M	USD	2 Qtrs
Unrealized gain on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.33M	USD	1 Quarter
Unrealized gain on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.15M	USD	2 Qtrs
Unrealized gain on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$530.00K	USD	1 Quarter
Unrealized gain on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$545.00K	USD	2 Qtrs
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$530.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$545.00K	USD	2 Qtrs
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$1.33M	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$1.15M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-927.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-73.25M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-32.43M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-32.53M	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-1.98	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.92	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.91	USD	1 Quarter
Weighted-average basic and diluted common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.18M	shares	2 Qtrs
Weighted-average basic and diluted common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.26M	shares	1 Quarter
Weighted-average basic and diluted common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	36.67M	shares	1 Quarter
Weighted-average basic and diluted common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	36.52M	shares	2 Qtrs

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-73.80M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-33.69M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$16.33M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$12.82M	USD	2 Qtrs
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$788.00K	USD	2 Qtrs
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-205.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$4.13M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.36M	USD	2 Qtrs
Net realized gains on sales and maturities of marketable securities	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$7.08M	USD	2 Qtrs
Unrealized losses (gains) on marketable equity securities	`AvailableForSaleEquitySecuritiesGrossUnrealizedGainLoss`	$-7.78M	USD	2 Qtrs
Unrealized losses (gains) on marketable equity securities	`AvailableForSaleEquitySecuritiesGrossUnrealizedGainLoss`	$31.66M	USD	2 Qtrs
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$1.90M	USD	2 Qtrs
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$1.38M	USD	2 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-373.00K	USD	2 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-442.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.71M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.42M	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$534.00K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$3.27M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$3.07M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.42M	USD	2 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-1.16M	USD	2 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-1.44M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.35M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$1.35M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$1.77M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$4.08M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.43M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-957.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-600.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-1.20M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-1.17M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.17M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-482.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-57.07M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-53.05M	USD	2 Qtrs
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$106.12M	USD	2 Qtrs
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$70.67M	USD	2 Qtrs
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$141.26M	USD	2 Qtrs
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$146.35M	USD	2 Qtrs
Sales of marketable debt securities	`ProceedsFromSalesOfMarketableDebtSecurities`	$2.29M	USD	2 Qtrs
Sales of marketable equity securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$7.12M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.91M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.01M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$77.19M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$27.13M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$3.98M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$5.13M	USD	2 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$607.00K	USD	2 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$365.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.59M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.49M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$24.71M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-20.42M	USD	2 Qtrs
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$95.55M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$76.61M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$56.20M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.84M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$95.55M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$76.61M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$56.20M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.84M	USD	Point-in-time
Non-cash consideration received for licenses granted	`NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1`	$1.12M	USD	2 Qtrs

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$487.05M	USD	Point-in-time
Balances	`StockholdersEquity`	$420.15M	USD	Point-in-time
Balances	`StockholdersEquity`	$397.86M	USD	Point-in-time
Balances	`StockholdersEquity`	$494.59M	USD	Point-in-time
Balances	`StockholdersEquity`	$508.85M	USD	Point-in-time
Balances	`StockholdersEquity`	$450.20M	USD	Point-in-time
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.13M	USD	2 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.98M	USD	2 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.37M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.82M	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$365.00K	USD	2 Qtrs
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$607.00K	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$8.32M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$16.33M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$12.82M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.10M	USD	1 Quarter
Unrealized gain on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$545.00K	USD	2 Qtrs
Unrealized gain on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$530.00K	USD	1 Quarter
Unrealized gain on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.15M	USD	2 Qtrs
Unrealized gain on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-33.76M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-33.69M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-73.80M	USD	2 Qtrs
Balances	`StockholdersEquity`	$487.05M	USD	Point-in-time
Balances	`StockholdersEquity`	$420.15M	USD	Point-in-time
Balances	`StockholdersEquity`	$397.86M	USD	Point-in-time
Balances	`StockholdersEquity`	$494.59M	USD	Point-in-time
Balances	`StockholdersEquity`	$508.85M	USD	Point-in-time
Balances	`StockholdersEquity`	$450.20M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.